Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Wanke

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Neurocritical Care|September 15, 2010
Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trialsR Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.
Clinical Neuroradiology|December 21, 2021
Radiation Exposure During Diagnostic and Therapeutic Angiography of Carotid-cavernous Fistula : A Retrospective Single Center Observational StudyMarcel Opitz, Georgios Alatzides, Sebastian Zensen, et al.
Journal of Alzheimer'S Disease : JAD|May 7, 2014
Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studiesLuigi Yuri Di Marco, Alberto Marzo, Miguel Muñoz-Ruiz, et al.
Acta Neurochirurgica. Supplement|August 15, 2012
Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2)R Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.
The Lancet. Neurology|June 7, 2011
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)R Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.
Stroke|March 10, 2012
Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coilingR Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.
Therapeutic Advances in Neurological Disorders|March 20, 2019
Relative health-related quality of life after treatment of unruptured intracranial aneurysms: long-term outcomes and influencing factorsPhilipp Dammann, Paula Wittek, Marvin Darkwah Oppong, et al.
Journal of Clinical Medicine|December 23, 2022
Predictors of Symptomatic Intracranial Hemorrhage after Endovascular Thrombectomy in Acute Ischemic Stroke Patients with Anterior Large Vessel Occlusion-Procedure Time and Reperfusion Quality DetermineYan Li, Natalie van Landeghem, Aydin Demircioglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trialChristoph Pöttgen, Wilfried Eberhardt, Andreas Grannass, et al.
European Radiology|October 10, 2006
Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patientsSusanne C Ladd, Joerg F Debatin, Andreas Stang, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Neurocritical Care|September 15, 2010
Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trialsR Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.
Clinical Neuroradiology|December 21, 2021
Radiation Exposure During Diagnostic and Therapeutic Angiography of Carotid-cavernous Fistula : A Retrospective Single Center Observational StudyMarcel Opitz, Georgios Alatzides, Sebastian Zensen, et al.
Journal of Alzheimer'S Disease : JAD|May 7, 2014
Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studiesLuigi Yuri Di Marco, Alberto Marzo, Miguel Muñoz-Ruiz, et al.
Acta Neurochirurgica. Supplement|August 15, 2012
Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2)R Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.
The Lancet. Neurology|June 7, 2011
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)R Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.
Stroke|March 10, 2012
Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coilingR Loch Macdonald, Randall T Higashida, Emanuela Keller, et al.
Therapeutic Advances in Neurological Disorders|March 20, 2019
Relative health-related quality of life after treatment of unruptured intracranial aneurysms: long-term outcomes and influencing factorsPhilipp Dammann, Paula Wittek, Marvin Darkwah Oppong, et al.
Journal of Clinical Medicine|December 23, 2022
Predictors of Symptomatic Intracranial Hemorrhage after Endovascular Thrombectomy in Acute Ischemic Stroke Patients with Anterior Large Vessel Occlusion-Procedure Time and Reperfusion Quality DetermineYan Li, Natalie van Landeghem, Aydin Demircioglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trialChristoph Pöttgen, Wilfried Eberhardt, Andreas Grannass, et al.
European Radiology|October 10, 2006
Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patientsSusanne C Ladd, Joerg F Debatin, Andreas Stang, et al.
Pageof 10